188 related articles for article (PubMed ID: 22553947)
1. The risk of osteopenia in premenopausal women with various sellar tumors.
Zhao Y; Gan X; Luo P; He Q; Guo Q; Zhang L; Zhang X; Zhang X; Fei Z
Gynecol Endocrinol; 2012 Dec; 28(12):945-8. PubMed ID: 22553947
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and magnitude of osteopenia in patients with prolactinoma.
Kayath MJ; Lengyel AM; Vieira JG
Braz J Med Biol Res; 1993 Sep; 26(9):933-41. PubMed ID: 8298528
[TBL] [Abstract][Full Text] [Related]
3. Various risks of osteoporosis in patients with pituitary adenomas.
Matsuyama J; Eshima N; Fukunaga T; Hori S; Kobayashi H; Isono M
J Bone Miner Metab; 2003; 21(2):91-7. PubMed ID: 12601573
[TBL] [Abstract][Full Text] [Related]
4. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of osteopenia in men with prolactinoma.
Naliato EC; Farias ML; Braucks GR; Costa FS; Zylberberg D; Violante AH
J Endocrinol Invest; 2005 Jan; 28(1):12-7. PubMed ID: 15816365
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2010 to 2016.
Aldahmani KM; Sreedharan J; Ismail MM; Philip J; Nair SC; Alfelasi M; Aziz W; Imran SA; Alkaabi J
Ann Saudi Med; 2020; 40(2):105-112. PubMed ID: 32241168
[TBL] [Abstract][Full Text] [Related]
7. The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins.
Bolanowski M; Zadrozna-Sliwka B; Jawiarczyk A; Syrycka J
Gynecol Endocrinol; 2010 Aug; 26(8):623-7. PubMed ID: 20218822
[TBL] [Abstract][Full Text] [Related]
8. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women.
Vartej P; Poiana C; Vartej I
Gynecol Endocrinol; 2001 Feb; 15(1):43-7. PubMed ID: 11293923
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
10. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
11. Ocular symptoms of tumors at sella turcica region.
Fu X; Wang H
Yan Ke Xue Bao; 1996 Sep; 12(3):166-8. PubMed ID: 9639845
[TBL] [Abstract][Full Text] [Related]
12. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
13. [Decreased bone mineral density in pre-menopause women with prolactinoma].
Bussade I; Naliato EC; Mendonça LM; Violante AH; Farias ML
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1522-7. PubMed ID: 18209896
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
16. Bone density in women with prolactinoma treated with dopamine agonists.
Naliato EC; Violante AH; Caldas D; Farias ML; Bussade I; Lamounier Filho A; Loureiro CR; Fontes R; Schrank Y; Loures T; Colao A
Pituitary; 2008; 11(1):21-8. PubMed ID: 17661178
[TBL] [Abstract][Full Text] [Related]
17. Decreased bone mineral density is common after autologous blood or marrow transplantation.
Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
[TBL] [Abstract][Full Text] [Related]
18. [Eye symptoms in hypophyseal adenomas, craniopharyngiomas and meningiomas of the anterior and middle cranial fossa].
Herold S; von Kummer R; von der Groeben C
Klin Monbl Augenheilkd; 1984 Dec; 185(6):495-504. PubMed ID: 6527504
[TBL] [Abstract][Full Text] [Related]
19. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis: evidence for bone loss in premenopausal women.
Tourinho TF; Stein A; Castro JA; Brenol JC
J Rheumatol; 2005 Jun; 32(6):1020-5. PubMed ID: 15940761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
